First Page | Document Content | |
---|---|---|
Date: 2014-11-19 14:29:44 | Preclinical and Clinical Activity of Anti-DLL4 (Demcizumab) in Combination with Gemcitabine Plus nab-Paclitaxel in Pancreatic Cancer Manuel Hidalgo*, Antonio Cubillo*, Robert Stagg**, Jakob Dupont**, Wan-Ching Yen**, TimAdd to Reading ListSource URL: s3.amazonaws.comDownload Document from Source WebsiteFile Size: 681,81 KBShare Document on Facebook |